KEY NOTE LECTURE UND PANEL DISCUSSION MIT NATIONALEN UND INTERNATIONALEN STAKEHOLDERN

Samstag, 17. November 13:30–16:15 Uhr
Sigmund Freud University, Raum 1002
1020 Vienna, Freudplatz 1

KEY NOTE LECTURE

HOW TO DEFINE INNOVATION?

How much are we willing or capable to pay for innovation?
Opportunities and Hurdles to access to innovation – a global perspective

Suerie Moon, MPA, PhD, Director of Research and Co-Chair, Forum on Global Governance for Health at Harvard University, Boston, MA, USA, Research Director Graduate Institute of International and Development Studies, Geneva, Switzerland


RESPONSE FROM INDUSTRY AND LESSONS LEARNED
Jürgen Raths, MD, Executive Consultant, Managing Director Cordée Consulting, Geneva

 

PANEL DISCUSSION

VALUE AND PRICE OF INNOVATION IN PHARMACEUTICALS AND DEVICES

Opportunities and Hurdles for access to innovation

Moderation: Univ.-Prof. Dr. Heinrich Klech, CEO VSCR

 

Teilnehmer:

Univ.-Prof. Dr. Ernst Agneter, MBA, Executive Board of Association of the Austrian Pharmaceutical Industry, Chairman of the Pharmig working group Health Economics & Reimbursement

Dr. Anna Bucsics, Former Department Head, Department of Pharmaceutical Affairs, Federation of Austrian Social Insurance Institutions

Dr. Martin Gleitsmann, Head of Department of Social Policy and Health, Austrian Federal Economic Chamber

Dr. Vladimir Kopernicky, Vice President, International Medical Affairs, Eli Lilly

Dr. Sylvia Nanz, Medical Director Pfizer Austria

Mag. Ingo Raimon, President of forum of the research based pharmaceutical industry Austria, FOPI

Dr. Wolfgang Wein, General Manager Merck Austria

Priv.-Doz. Dr. phil. Claudia Wild, Director of Ludwig Boltzmann Institut, HTA

 

Wir ersuchen bis zum 12.11.2018 um Ihre Anmeldung unteroffice@vscr.at